165 related articles for article (PubMed ID: 20655882)
1. TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation.
Bertomeu T; Zvereff V; Ibrahim A; Zehntner SP; Aliaga A; Rosa-Neto P; Bedell BJ; Falardeau P; Gourdeau H
Biochem Pharmacol; 2010 Nov; 80(10):1572-9. PubMed ID: 20655882
[TBL] [Abstract][Full Text] [Related]
2. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
3. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P
Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531
[TBL] [Abstract][Full Text] [Related]
4. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
[TBL] [Abstract][Full Text] [Related]
5. [2-11C]isopropyl-, [1-11C]ethyl-, and [11C]methyl-labeled phenoxyphenyl acetamide derivatives as positron emission tomography ligands for the peripheral benzodiazepine receptor: radiosynthesis, uptake, and in vivo binding in brain.
Zhang MR; Ogawa M; Maeda J; Ito T; Noguchi J; Kumata K; Okauchi T; Suhara T; Suzuki K
J Med Chem; 2006 May; 49(9):2735-42. PubMed ID: 16640334
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the 18 kDa translocator protein (TSPO) by neoplastic and inflammatory cells in mouse tumors of breast cancer.
Zheng J; Boisgard R; Siquier-Pernet K; Decaudin D; Dollé F; Tavitian B
Mol Pharm; 2011 Jun; 8(3):823-32. PubMed ID: 21417480
[TBL] [Abstract][Full Text] [Related]
7. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.
Margiotta N; Denora N; Ostuni R; Laquintana V; Anderson A; Johnson SW; Trapani G; Natile G
J Med Chem; 2010 Jul; 53(14):5144-54. PubMed ID: 20568783
[TBL] [Abstract][Full Text] [Related]
8. The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line.
Levin E; Premkumar A; Veenman L; Kugler W; Leschiner S; Spanier I; Weisinger G; Lakomek M; Weizman A; Snyder SH; Pasternak GW; Gavish M
Biochemistry; 2005 Jul; 44(29):9924-35. PubMed ID: 16026165
[TBL] [Abstract][Full Text] [Related]
9. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines.
Veenman L; Levin E; Weisinger G; Leschiner S; Spanier I; Snyder SH; Weizman A; Gavish M
Biochem Pharmacol; 2004 Aug; 68(4):689-98. PubMed ID: 15276076
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Sutter AP; Maaser K; Gerst B; Krahn A; Zeitz M; Scherübl H
Biochem Pharmacol; 2004 May; 67(9):1701-10. PubMed ID: 15081869
[TBL] [Abstract][Full Text] [Related]
11. Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis.
Stoebner PE; Carayon P; Casellas P; Portier M; Lavabre-Bertrand T; Cuq P; Cano JP; Meynadier J; Meunier L
Cell Death Differ; 2001 Jul; 8(7):747-53. PubMed ID: 11464219
[TBL] [Abstract][Full Text] [Related]
12. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.
Hardwick M; Fertikh D; Culty M; Li H; Vidic B; Papadopoulos V
Cancer Res; 1999 Feb; 59(4):831-42. PubMed ID: 10029072
[TBL] [Abstract][Full Text] [Related]
13. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.
Gulyás B; Makkai B; Kása P; Gulya K; Bakota L; Várszegi S; Beliczai Z; Andersson J; Csiba L; Thiele A; Dyrks T; Suhara T; Suzuki K; Higuchi M; Halldin C
Neurochem Int; 2009 Jan; 54(1):28-36. PubMed ID: 18984021
[TBL] [Abstract][Full Text] [Related]
14. TLN-4601, a novel anticancer agent, inhibits Ras signaling post Ras prenylation and before MEK activation.
Boufaied N; Wioland MA; Falardeau P; Gourdeau H
Anticancer Drugs; 2010 Jun; 21(5):543-52. PubMed ID: 20220516
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of alcohol to adult rats inhibits leydig cell activity: Time course of effect and role of nitric oxide.
Herman M; Kang SS; Lee S; James P; Rivier C
Alcohol Clin Exp Res; 2006 Sep; 30(9):1479-91. PubMed ID: 16930210
[TBL] [Abstract][Full Text] [Related]
16. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor.
Maeda J; Higuchi M; Inaji M; Ji B; Haneda E; Okauchi T; Zhang MR; Suzuki K; Suhara T
Brain Res; 2007 Jul; 1157():100-11. PubMed ID: 17540348
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolo-1,5-benzoxazepines induce apoptosis in HL-60, Jurkat, and Hut-78 cells: a new class of apoptotic agents.
Zisterer DM; Campiani G; Nacci V; Williams DC
J Pharmacol Exp Ther; 2000 Apr; 293(1):48-59. PubMed ID: 10734152
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
19. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.
Castellano S; Taliani S; Viviano M; Milite C; Da Pozzo E; Costa B; Barresi E; Bruno A; Cosconati S; Marinelli L; Greco G; Novellino E; Sbardella G; Da Settimo F; Martini C
J Med Chem; 2014 Mar; 57(6):2413-28. PubMed ID: 24580635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
